Saline Breast Implant Makers Must Submit PMAs By Nov. 17, FDA Says

Manufacturers of saline breast implants have until Nov. 17 to file either a premarket approval application, product development protocol or an investigational device exemption for their products or remove them from commercial distribution, FDA says in an Aug. 19 final rule.

More from Archive

More from Medtech Insight